Sphingolipids in inflammation: pathological implications and potential therapeutic targets.
about
The genetic and epigenetic landscapes of the epithelium in asthmaA large-scale, consortium-based genomewide association study of asthmaEvaluation of the role of secretory sphingomyelinase and bioactive sphingolipids as biomarkers in hemophagocytic lymphohistiocytosisIn vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibodyExpression of LPP3 in Bergmann glia is required for proper cerebellar sphingosine-1-phosphate metabolism/signaling and developmentEmerging targets in lipid-based therapyAltering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in ratsCD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent toleranceCeramide synthesis regulates T cell activity and GVHD development.Insulin sensitivity is reflected by characteristic metabolic fingerprints--a Fourier transform mass spectrometric non-targeted metabolomics approachS1pping fire: Sphingosine-1-phosphate signaling as an emerging target in inflammatory bowel disease and colitis-associated cancerA hypothesis concerning a potential involvement of ceramide in apoptosis and acantholysis induced by pemphigus autoantibodies.Discovery and evaluation of inhibitors of human ceramidase.HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate.Blood sphingolipidomics in healthy humans: impact of sample collection methodology.Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.Blockade of lysosomal acid ceramidase induces GluN2B-dependent Tau phosphorylation in rat hippocampal slices.Integrative genetic analysis of allergic inflammation in the murine lungSphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism.Epidermal fatty acid-binding protein protects nerve growth factor-differentiated PC12 cells from lipotoxic injuryApoptotic sphingolipid ceramide in cancer therapy.Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidase.Indoleamine 2,3-dioxygenase 1 (ido1) is involved in the control of mouse caput epididymis immune environmentAssociation signals unveiled by a comprehensive gene set enrichment analysis of dental caries genome-wide association studies.Serum metabolome and lipidome changes in adult patients with primary dengue infection.Lipid Analysis of Airway Epithelial Cells for Studying Respiratory DiseasesMany ceramides.Ceramide kinase regulates TNFα-stimulated NADPH oxidase activity and eicosanoid biosynthesis in neuroblastoma cellsInterictal, circulating sphingolipids in women with episodic migraine: A case-control study.Neuroinflammatory paradigms in lysosomal storage diseases.A lipidomic analysis approach to evaluate the response to cholesterol-lowering food intakeEnglerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinomaIntegrating Microbiome and Metabolome Data to Understand Infectious Airway Disease.Improved motor and cognitive performance with sodium nitrite supplementation is related to small metabolite signatures: a pilot trial in middle-aged and older adultsInhibition of de novo ceramide biosynthesis by FTY720 protects rat retina from light-induced degeneration.Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects.Quantification of phospholipids classes in human milkMetabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease.Sphingomyelin Liposomes Containing Soluble Leishmania major antigens Induced Strong Th2 Immune Response in BALB/c MiceBeyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders.
P2860
Q28067559-3F976067-A73F-45F3-AC59-C690477021DDQ28293885-24438912-E041-45AE-BC5D-2E19D03786C0Q28293977-D2CBF4AE-8666-4AA3-BA48-472B35531375Q28482145-4A412FDC-1195-4CA4-B9A0-371CF21C2FEEQ28508004-4F6CF97D-D1E2-46C9-9362-969BA5301990Q28655456-A8C33E8B-030D-4014-B8F6-97595219867AQ28742345-9AB4E6AB-A91B-4E06-BE94-6833926F1BF0Q33518472-F262FBDC-98AC-4638-A66F-AF4C1D999676Q33703218-F7052FDA-ADDC-42BB-8085-0D50BE66F6CBQ33728538-0557433B-18BE-4D73-BDD4-B6E42DD22A4EQ33857794-CB400BD2-8497-4031-8566-A4B20CE2DBF4Q33890589-1594E8D8-3437-4B15-93E7-AF242F12AF22Q34008335-0A267336-A0CE-4833-B5B9-A588C8EDA6A3Q34053101-36746AEC-8E87-4053-9D86-FC8D1927D386Q34116310-53EA5E39-9A00-4D17-BD52-ABFBFD130514Q34209320-FA9B4F14-DE87-41ED-80B3-011F77650EEAQ34223486-7974DAF1-F0C0-48A7-8BCC-3D589B394565Q34305586-9894F574-78D4-4B16-8098-B799762CB50EQ34571684-90B76E75-D0E7-4E88-8424-FF8665A2DF54Q34734555-B7B44E4B-DED9-46BE-BC96-68C4550B8B2FQ34736760-D968A43D-971F-4B32-A902-18EC3FC4A4C6Q34787157-B7B448C0-5615-4BDF-907C-092D8F913C69Q34805596-0EC5F3F3-15DA-402E-B154-C161E71325A1Q34965483-15288D07-C01F-4775-9C42-A46E3F696899Q34965777-4A0B593F-CB6C-453C-BA31-5986B9414BFBQ35138292-8CFE1CE2-5DB4-416E-9994-49002C3389A3Q35149996-0AA74A93-BC33-40FA-B6CD-752E5BA4CAC6Q35918569-9AECA11F-8BE2-4044-AEEF-663402086263Q36166971-8819C039-6653-45B9-8436-63F41B73EDDDQ36232187-DE33B6C4-3976-4F55-A8A3-411C0245912AQ36301541-E1C64B83-71A7-4269-A855-53DACF40C4B6Q36308931-5A892680-C34E-4F09-B82C-327642EFFD78Q36409064-8F44C8D6-5D49-49B8-835C-F57C4E5E6729Q36411120-3A45742F-CFE9-4A05-B4C5-EE1E3BF3EE9CQ36822578-7CB8F6A7-2601-4658-9536-962737043750Q37151032-84562317-F57B-4CA7-84C3-3A1E764B3CE4Q37189069-F253B13D-7D1B-403F-B287-5F192A7734A8Q37191286-652777CA-4309-4D40-94D5-44B0132F9751Q37246219-5DFF86C0-1933-4557-BD0E-0BD6D0FE96EFQ37396760-856FDDDD-2E2F-4D96-9AFD-0201A1027536
P2860
Sphingolipids in inflammation: pathological implications and potential therapeutic targets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sphingolipids in inflammation: ...... potential therapeutic targets.
@en
Sphingolipids in inflammation: ...... potential therapeutic targets.
@nl
type
label
Sphingolipids in inflammation: ...... potential therapeutic targets.
@en
Sphingolipids in inflammation: ...... potential therapeutic targets.
@nl
prefLabel
Sphingolipids in inflammation: ...... potential therapeutic targets.
@en
Sphingolipids in inflammation: ...... potential therapeutic targets.
@nl
P2860
P1476
Sphingolipids in inflammation: ...... potential therapeutic targets
@en
P2093
Graeme F Nixon
P2860
P304
P356
10.1111/J.1476-5381.2009.00281.X
P407
P577
2009-06-25T00:00:00Z